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SUMMARY 
Animal African trypanosomiasis (AAT) also known as Nagana is a resurgent disease in Africa. 
Medicinal plants are being used in less developed countries for the treatment of various diseases 
including trypanosomiasis, due to the high cost of currently available drugs. Most of these plants 
have been useful sources of treatment of various diseases based on information obtained from 
folk medicine but have not been scientifically certified. Here, we investigated the in vitro and in 
vivo anti-trypanosomal potentials of the methanol extract of Aformorsia laxiflora and Khaya 
senegalensis against T. b. brucei. Phytochemical screening as well as LD50 of the plant extracts 
was carried out following standard procedures. Parasitemia was monitored daily while Packed 
Cell Volume was determined at three time points (days 1, 4 and 7) during the course of the 
infection. The phytochemical analysis showed the presence of saponins, alkaloids, flavonoids, 
antraquinones, resins and tanins. However, steriods/terpenoids were absent in K. senegalensis 
but present in A. laxiflora. The toxicity of methanol extract of both A. laxiflora and K. 
senegalensis was above 5000mg/kg body weight. Methanol extracts of A. laxiflora (leaves) and 
K. senegalensis (stem bark) showed promising trypanocidal potential in vitro against T. b. brucei 
at concentrations of 10, 15, 25mg/ml and 40 and 20mg/ml respectively. At these concentrations, 
both extracts immobilized the parasites within 55mins post-incubation. In general, A. laxiflora 
leaf extract demonstrated prophylactic activity against T. b. brucei in vivo at a dose of 500mg/Kg 
body weight particularly in group C animals where a delayed pre-patent period (6 days post-
infection), extended survival (14 days post-infection) and significant (P<0.05) reduction in the 
parasite burden confirmed by an absence of anemia (PCV 47.00±0.8 %) was observed when 
compared to the infected untreated control group. K. senegalensis extract on the other hand did 
not show anti-trypanosomal activity in the treated groups (1, 2, and 3). Based on these 
observations, it was therefore deduced that the methanol extract of leaves of A. laxiflora 
possessed the ability to ameliorate the burden of the disease and could be a plausible candidate 
for drug development against the disease. 
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African animal trypanosomiasis (AAT) is 
still a major and the most important 
constraint to livestock and agricultural 
production in tropical Africa (Isaac et al., 
2017; Courtin et al., 2008). It has been 
considered as a threat to poverty alleviation 
programs in the continent. AAT is mainly 
caused by Trypanosoma congolense, and to 
a lesser extent by Trypanosoma vivax and 
Trypanosoma brucei brucei species 
(Vanden, 2001). Tsetse flies, which are the 
vectors of the African trypanosomes, are 
responsible for the cyclical transmission of 
this parasitic protozoan between numerous 
vertebrate hosts. All domestic animals can 
be affected by Nagana and the symptoms are 
fever, listlessness, emaciation, hair loss, 
discharge from the eyes, oedema, anemia 
and paralysis. As the illness progresses the 
animals weakens more and more and this 
will eventually lead to the death of the 
animal if untreated. Interestingly, these 
parasites cause relatively mild infections in 
wild animals while in domestic animals they 
cause a severe, often-fatal disease (Chechet, 
2015).  
There is currently an absence of effective 
alternative drug for the treatment and control 
of trypanosomiasis, therefore, the search for 
active substances of natural origin is of 
paramount important (Adeiza 2010). 
Coupling to the side effects of the available 
trypanocidal drugs, the resistance 
mechanisms employed by trypanosomes are 
major factors that contribute to the 
difficulties encountered in the managements 
and treatment of the disease. This challenge 
therefore calls for an urgent search for a 
novel chemotherapy for the treatment and 
management of AAT. 
It is estimated that two thirds of the world 
population still rely on traditional medical 
remedies, mainly plants, because of limited 
availability and affordability of 
pharmaceutical medicines (Tagboto and 
Townson, 2001). This explains why a lot of 
current research focuses on natural 
molecules and plant-derived products as 
they can be sourced easily, locally available 
and can be selected on the basis of their 
ethno medicinal use (Verpoorte et al., 2005). 
The use of an alternative drug has been 
recommended as a measure to avoid the 
development of resistant pathogenic 
organism including trypanosomes (Abdul, 
1990). The use of herbal preparations for the 
treatment of this disease still holds a strong 
potential in that some ethnomedicinal plants 
have been demonstrated to contain potent 
trypanocides (Igweh and Onabanjo, 1989; 
Owolabi et al., 1990; Nok et al., 1993; 
Atawodi, 2005). 
Natural products are still major potential 
sources of innovative therapeutic agents for 
various conditions, including infectious 
diseases as they represent an unmet source 
of chemical diversity (Clardy and Walsh, 
2004). Indeed, several antiparasitic drugs 
have been derived directly from natural 
sources, such as quinine, artemisinin and 
atovaquone as antimalarials and 
amphotericin B as antileishmanial drug. 
Plants possess valuable organic substances, 
which have potential value for the treatment 
of diseases therefore, there is the need to 
harness these potentials in the treatment and 
control of diseases therefore making it 
necessary to investigate such plants.  To 
curb the menace of this disease Human 
African Trypanosomiasis, the use of 
alternate drugs has been recommended as a 
measure to avoid the development of 
resistant pathogenic organism (Abdul, 
1990).   
Afrormosia laxiflora, is a plant that is widely 
distributed in tropical Africa, extending 
from Senegal to Sudan (Von Ffranziska, 
1996). Various parts of this plant have been 
used previously in Nigerian traditional 
medicine as medication or remedy for a 




number of diseases. The bark is widely used 
as a remedy for fever, malaria and other 
diseases with symptoms of icterus. An 
aqueous extract of the leaves given to 
patients orally for a long time has been used 
as a prophylactic remedy for malaria (Von 
Ffranziska, 1996).  
Khaya senegalensis (Juss), is highly reputed 
for its numerous medicinal uses and has 
been reported to be used indigenously in the 
treatment of trypanosomiasis (Atawodi et 
al., 2001). The plant has also been reported 
to possess an in vitro antitrypanosomal 
activity (Wurochekke and Nok, 2004; 
Atawodi, 2005). The in vitro activities of the 
aqueous and ethanol extracts of the leaves, 
root bark and stem bark of K. senegalensis 
against T. evansi has been reported (Umar et 
al., 2010). However, the in vitro and in vivo 
anti-trypanocidal potentials of methanol 
extracts of A. laxiflora (leaves) and K. 
senegalensis (stem bark) are yet to be 
evaluated. This study therefore is aimed at 
investigating the in vitro and in vivo anti-
trypanocidal potentials of A. laxiflora leaves 
and K. senegalensis stem bark against T. b. 
brucei. 
 
MATERIALS AND METHODS 
Parasites 
Trypanosoma brucei brucei was obtained 
from the Department of Parasitology and 
Entomology, Faculty of Veterinary 
Medicine, Ahmadu Bello University Zaria 
Kaduna State, Nigeria. Two (2) donor rats 
were infected with T. brucei brucei blood 
from a donor rat at peak parasitemia. The 
parasites were subsequently maintained by 
serial parasite passages in albino rats. The 
experimental animals were inoculated with 
0.2ml containing 10
6
 parasites/ml estimated 
using Rapid Matching Method (Herbert and 
Lumsden, 1976).  
 
Parasite authentication by Polymerase 
Chain Reaction (PCR)  
Polymerase Chain Reaction (PCR) was 
performed using Phusion Blood direct kit 
(Finzymes) and ITS-1 generic primers to 
further authenticate the identity of the 
parasites. Briefly, 1µl of blood from an 
infected animal was included in the first 
round of PCR. The PCR was performed in a 
20µl reaction volume containing 10µl of the 
Phusion buffer (Finzymes), 1.0µl of each 
outer primer (10 µM), 0.4µL of Phusion 
enzyme, 6.6µL of double distilled water and 
1µL of blood that served as template in the 
first reaction. The cycling conditions were 
as follows: 1 cycle at 98
0
C for 300 seconds 
followed by 35 cycles at 98
0
C for 1 second, 
57
0
C for 5 seconds, 72
0
C for 20 seconds and 
a final extension at 72
0
C for 60 seconds. At 
the end of the reaction, the tubes were 
centrifuged at 1800 rpm for 3 minutes and 
1µL of the supernatant was used as template 
in the second reaction. The nested PCR was 
performed using a 25µL reaction volume 
containing 1µL (1ng/µL) template DNA, 
25µM of each primer, 10mM dNTPs, 25mM 
10x Dream Taq polymerase buffer, 5U/µL 
Dream Taq polymerase to a reaction volume 
of 25µL. Cycling conditions were as 
follows: 1 cycle at 95
0
C for 300 seconds 
followed by 30 cycles at 95
0
C for 60 
seconds, 56
0
C for 60 seconds, 72
0
C for 30 
seconds, and final extension 72
0
C for 220 
seconds. The products were resolved by 
electrophoresis (45 minutes to 1 hour at 
100V) on 1.5 or 2% Agarose gels stained 
with G-Stain (Serva®) and bands were 
visualized using GelDoc-It
2
 Imaging System 
(Analytik Jena AG Jena, Germany). 
 
Experimental Animals 
Thirty albino rats, which weighed between 
130-178g, were obtained from the 
Department of Pharmacology, Faculty of 
Pharmaceutical sciences, Ahmadu Bello 
University Zaria Kaduna State, Nigeria. 
Each group of experimental animals was 
housed in a 15x30cm cage with metal tops 
that was thoroughly cleaned. Bedding 
materials consisting of wood shavings (saw 
dust) were used and changed ones a week. 
The rats were fed daily with commercial rat 
chow (Vital Feeds, Jos, Nigeria) with 
drinking water ad libitum. All experimental 




animals were acclimatized for two (2) weeks 
before the commencement of the 
experiment. 
 
Sample Collection and identification  
Afrormosia laxiflora leaves and Khaya 
senegalensis stem bark was collected from 
the botanical garden of Biological Sciences, 
Department, Ahmadu Bello University 
Zaria, Nigeria. Both plants were identified, 
authenticated and voucher numbers was 
assign to them.   
 
Sample Preparation 
The leaves of A. laxiflora and the stem bark 
of K. senegalensis was collected and dried 
under shade for 3 weeks in Mary Hallaway 
Teaching Laboratory, Department of 
Biochemistry, Ahmadu Bello University 
Zaria, Nigeria. The dried samples of both 
plants were ground to fine powder with 
mortar and pestle and then stored in dry 
containers until needed. 
 
Sample Extraction and storage 
Cold extraction of both plant samples was 
carried out. 100g each of the fine powdered 
A. laxiflora and K. senegalensis was soaked 
in 300ml of 70% methanol and sequentially 
extracted by shaking for 6 hours on wrist 
action shaker.  The preparations were left at 
room temperature to stand for 24 hours. 
Both preparations were filtered through 
Whatmann’s No.1 filter paper and extracts 
were concentrated to dryness on a water 
bath at 40
0
C. The two extracts were packed 
separately in polythene bags and stored in 
the refrigerator at 4
0
C until needed 
(Atawodi, 2005). 
 
Qualitative phytochemical screening of 
plants 
Test for flavonoids 
For the confirmation of flavonoids in the 
leaves powder, 0.5 g of plant extract was 
placed in a test tube and 10 ml of distill 
water as well as 5 ml of dilute ammonia 
solution were added to a portion of the 
aqueous filtrate of the plant extract followed 
by addition of 1 ml concentrated H2SO4. 
Indication of a yellow color shows the 
presence of flavonoids in each extract 
(Wadood et al., 2013). 
 
Test for alkaloids 
The procedure used for determination of 
alkalolids in the plant samples is similar to 
that described by (Wadood et al., 2013). 
Briefly, 0.2 g of leaves powder was added to 
a glass test tube that has 3 ml of hexane. The 
powder and hexane were thoroughly mixed, 
shaken well, and filtered. To the hexane and 
leaves extract mixture, 5 ml of 2% HCl were 
added, and the mixture heated until boiling. 
The mixture was then filtered, and 1-3 drops 
of picric acid were added to the hexane, HCl 
and leaves extract filtrate. The presence of 
alkaloids in the samples was confirmed by 
the yellow- colored precipitate that was 
formed. 
 
Test for terpenoids 
An amount of 0.8 gram of the leaves powder 
was placed in a test tube, then 10 ml. of 
methanol was poured in it, shaken well and 
filtered. Five ml of the plant extract of plant 
samples was taken. Then 2 ml of chloroform 
were mixed with the extracts and 3 ml of 
sulphuric acid were added. Formation of 
reddish brown color indicates the presence 
of terpenoids in the selected plants (Wadood 
et al., 2013). 
 
Test for tannins 
Crude extract of the plants powder was 
mixed with 2 ml of 2% solution of FeCl3. A 
blue-green or black coloration indicated the 
presence of tannins (Yadav and Agarwala, 
2011). 
 
Test for steroids 
Leaves powder from both plants was mixed 
with 2 ml of chloroform and concentrated 
H2SO4 was added sidewise. A red color 
produced in the lower chloroform layer 
indicated the presence of steroids. Another 
test was performed by mixing crude extract 
with 2 ml of chloroform. Then 2 ml of each 




of concentrated H2SO4 and acetic acid were 
poured into the mixture. The development of 
a greenish coloration indicated the presence 
of steroids (Yadav and Agarwala, 2011). 
 
Test for saponins 
The crude extracts were mixed with 5 ml of 
distilled water in a test tube and it was 
shaken vigorously. The formation of stable 
foam was taken as an indication for the 
presence of saponins (Yadav and Agarwala, 
2011). 
 
Test for Anthraquinones 
The ether and chloroform maceration from 
both plants was filtered and 1mL of this 
solution was treated with 1mL of 10% 
sodium hydroxide solution. A red coloration 
indicates the presence of quinines. 
 
In vitro assessment 
Plant extracts were prepared from a 40 
mg/ml stock solution from which dilutions 
were made. For A. laxiflora, four different 
concentrations of 2, 4, 10 and 15mg/ml were 
prepared while three different concentrations 
of 10, 20 and 40mg/ml were prepared for K. 
senegalensis. 25mg/ml of the standard drug 
(Diminazene aceturate) was also constituted. 
The in vitro assays were performed in 
triplicates in microtitre plates. Aliquots of 
50µl of 1x10
9
 parasites/ml of parasitized 
blood were incubated with 50µl of the 
different aforementioned concentrations of 
both plant extracts and the standard. A 
positive control containing 50µl of 
parasitized blood incubated in 50µl 
Phosphate buffered Saline Glucose (pH 7.4), 
was also prepared. 5 µl of incubated cocktail 
was placed on microscope slides and 
observed under a light microscope at 5 
minutes intervals over a period of 1 hour. A 
cessation or drop in motility of the parasites 
in treated blood compared to that of 
parasite-loaded control blood without extract 
was taken as a measure of anti-trypanosomal 
activity, since motility constitutes a 
relatively reliable indicator of the viability 
of most zooflagellate parasites (Atawodi, 
2005). The shorter the time of cessation of 
motility of the parasite, the more active the 
extract was considered to be (Atawodi et al., 
2001) 
 
Median Lethal Dosed (LD50) 
The acute toxicity of the methanolic extracts 
of A. laxiflora and K. senegalensis was 
determined by Lorke’s method 1983. The 
experimental animals were administered 
with the preparation of the methanolic 
extracts of both plants intraperitoneally, and 
it was conducted in two phases. In the first 
stage, nine experimental rats were divided 
into three different groups on the basis of 
their weights with each group containing 
three rats. Following Lorke’s method, in the 
first phase of experiment, 10, 100 and 
1000mg/kg body weight of the crude 
extracts solution was administered to the 
first, second and the third groups 
intaperitoneally respectively. The animals 
were placed under observation for 24 hours 
to monitor their behaviors and some signs 
and symptoms of toxicity as well as if 
mortality will occur. In the second phase of 
the experiment, three rats were divided into 
three different groups on the basis of their 
weight consisting of 1 animal per group. To 
the three different groups, 1600, 2900 and 
5000mg/kg body weight of the crude 
methanolic extracts was administered to the 
first, second and the third group 
intraperitoneally respectively. The animals 
were placed under observation for 24 hours 
to monitor their behaviors and some signs 
and symptoms of toxicity as well as if 
mortality will occur.   
The LD50 was calculated by the following 
formula: 
 
D0 = Highest dose that gave no mortality, 
D100 = Lowest dose that produced mortality. 
 
In vivo Prophylactic Studies of A. laxiflora 
and K. senegalensis 
A total of 30 rats were used for the in vivo 
experiment. The rats were divided into five 




different groups with each group containing 
three rats. Rats to be administered with A. 
laxiflora were labelled groups A-E while 
those to be administered with K. 
senegalensis were labelled groups 1-5.    
Animals in groups A, B, C and 1, 2, 3 were 
administered 500mg/kg body weight of A. 
laxiflora and K. senegalensis respectively, at 
different time intervals prior to the 
experimental infection. Groups C and 3 
were administered three doses (once daily 
for 3 days) of 500mg/kg body weight of the 
crude extracts at 24 hours interval. Groups B 
and 2 were administered two doses (once 
daily for two days) of 500mg/kg body 
weight of the crude extracts at 24 hours 
intervals. Groups A and 1 were administered 
a single dose of 500mg/kg body weight of 
the crude extract. Groups B/2 and A/1 
received the first doses of extracts at 24 and 
48 hours intervals respectively after groups 
C/3 received the first dose of extracts. 
Groups D and 4 were positive controls that 
were infected but untreated. While groups E 
and 5 were the negative controls (uninfected 




intraperitoneally 24 hours after groups A 
and 1 received prophylactic treatment.  
 
Determination of Parasit emia 
Parasite count was monitored daily in the 
infected groups and determined 
microscopically at 40 magnification using 
the “Rapid Matching” method of Herbert 
and Lumsden 1976. Briefly, the method 
involves microscopic counting of parasites 
per field in pure blood or blood 
appropriately diluted with phosphate 
buffered saline (PBS, pH 7.4). Logarithmic 
values of these counts obtained by matching 
with the table of Herbert and Lumsden 
(1976) is converted to antilog to provide 
absolute number of trypanosomes per ml of 
blood (Atawodi, 2003). 
Pre-patent period was determined when the 
first T.b.brucei parasite was seen in the 
blood of the infected animals. 
Packed Cell Volume (PCV) 
The PCVs of all the animals from each 
group were determined on days 1, 4 and 7 
post infection by Microhaematocrit method 
described by Coles (1974). The blood was 
directly taken from the tails of the rats (also 
known as tail bleeding) into heparinized 
capillary tubes by capillary action to about 
75% of its length.  The ends of the tubes 
were sealed with a flame using Bunsen 
burner. The sealed tubes were placed in a 
microhaematocrit centrifuge, with the sealed 
ends near the outside rim of the centrifuge 
(touching the rim).  The cover of the 
centrifuge was tightened to prevent blood 
spillage and centrifuged for 5 minutes. 
Thereafter, the capillary tubes were placed 
in a graphic reader and the packed cell 




All data was analyzed using One Way 
Analysis of variance (ANOVA) expressed 
as means ± standard deviation of duplicate 
measurements using Gr aph Pad Prism 7 
software Version 7.0a. The significant level 
was set at (P < 0.05). 
 
RESULT 
Polymerase Chain Reaction analysis 
The band in plate 1 runs at about 450bp 
indicating that the parasite is T. b. brucei. 
 
Qualitative phytochemical analysis 
The percentage yield of crude Afromosia 
laxiflora and Khaya senegalensis leaf 
extracted using methanol was 11.27 and 
15.3% respectively. 
The phytochemical screening of Afromosia 
laxiflora and Khaya senegalensis leaves 
showed that the methanol extracts contain 
Saponins, Alkaloids, Flavonoids, 
Antraquinones, Resins and Tanins and 
Steriods/Terpenoids. However, 
Steriods/Terpenoids was absent in Khaya 
sensgalensis (Table 1). 




Figures 1 and 2 showed a dose-dependent 
trypanocidal effect of methanolic extract of 
A. laxiflora and K. senegalensis against T. b. 
brucei trypomastigotes. After 35 minutes 
post-incubation a reduction of 83.91%, 
99.94%, 93.93%, and 53.82% (6.31 ± 0.44, 
0.25 ± 0.21, 2.38±0.17, and 20.88 ± 1.01 
x10
7
 Trypanosomes/ml of blood) of live 
parasites was observed at concentrations of 
25mg/ml (Diminazene aceturate), 40, 20 and 
10mg/ml of K. senegalensis. After 50 
minutes, a reduction of 98.45%, 96.84%, 
96.84% and 87.40% (0.79 ± 0.47, 1.59 ± 
0.43, 3.16 ± 0.84, 3.16 ± 0.37 and 12.59 ± 
0.19 x10
7
 Trypanosomes/ml of blood) of 
live trypomastigotes was observed at 
concentrations of 25mg/ml (Diminazene 
aceturate), 15, 10, 4 and 2mg/ml of A. 
laxiflora respectively. After 60 minutes in 
maintenance medium, there were no living 
parasites observed at 40 and 20mg/ml (K. 
senegalensis) as well as 15 and 10mg/ml (A. 
laxiflora). However, a significant decrease 
(P<0.05) in number of live trypomastigotes 
was observed in medium containing 4, 
2mg/ml (A. laxiflora) and 10mg/ml (K. 
senegalensis) after 60 minutes. After 40 and 
55 minutes of incubation, the highest 
concentrations of K. senegalensis (40mg/ml) 
and A. laxiflora (15mg/ml) respectively 
cleared parasites in the medium earlier or at 
the same time when compared with the 
group incubated in the standard drug. The 
positive controls remained motile  
 
throughout the duration of the experiment. 
 
In Vitro Evaluation 
At the end of the LD50 analysis, the methanol 
crude extract of both A. laxiflora and K. 
senegalensis was observed to have no toxicity 
effect on the experimental animals at 
concentrations of 10, 100, 1000, 1500, 2900 
and 5000mg/kg body weight since no mortality 
was observed at the concentration of 
5000mg/kg b.w for 24 hours. Therefore, it was 
concluded that the toxicity of methanol extract 
of both A .laxiflora and K. senegalensis was 
above 5000mg/kg body weight, hence the 
choice of the dose concentration for the in vivo 
experiment. 
 
In Vivo Prophylactic Studies 
The in vivo prophylactic effect of the methanol 
extract of A. laxiflora and K. senegalensis  
Plate 1: Electrophorograph of T.  b. brucei: 
M= DNA Mass ruler and S=sample (T. b. 
brucei) 
 
TABLE I: Phytochemical analysis of methanol extract of Afromosia laxiflora and Khaya 
sensgalensis leaves 
Component Khaya senegalensis Afromosia laxiflora 
Saponins + + 
Alkaloids + + 
Flavonoids + + 
Antraquinones + + 
Tannins + + 
Steroids/Terpenioids + - 
+ indicates the presence of the test compounds, while – indicates the absence of the test 
compounds 





against T. b. brucei is shown in 
figures 3 and 4. Animals in groups 
A, B, C and D developed mean 
parasitemia (pre-patent) of 1.59 ± 
0.45, 0.79 ± 0.14, 0.79 ± 0.45, 1.59 
± 0.47 (x10
7
 Trypanosomes/ml of 
blood) on days 3, 4, 6 and 4 
respectively. The mean parasitemia 
peaked at 50.12 ± 0.51, 25.12 ± 
0.92, 12.59 ± 0.48 and 100.00 ± 
0.45 (x10
7
 Trypanosomes/ml of 
blood) on days 9, 10, 14 and 9 
respectively. On the other hand, 
animals in groups 1, 2 and 3 
developed parasitemia of 0.53 ± 
0.07, 0.26 ± 0.03 and 0.26 ± 0.03 
(x10
7
 Trypanosomes/ml of blood) 
on day 2, group 4 animals showed 
parasitemia of 1.06 ± 0.35 on day 3. 
While groups 1, 2 and 3 peaked at 
mean parasitemia of 5.01 ± 0.42, 
4.17 ± 0.49 and 3.35 ± 0.28 (x10
7
 
Trypanosomes/ml of blood) 
respectively; group 4 peaked at 
5.02 ± 0.45 on day 8. The mean 
parasitemia displayed between the 
groups was statistically 
insignificant (P>0.05). 
 
Packed Cell Volume (PCV) 
There was significant (P < 0.05) 
reduction in the mean PCV from on 
days 4 and 7 post-infection among 
animals administered K. 
senegalensis such that the animals 
developed significant anemia on 
day 7 which is comparable with the 
mean PCV observed in the infected 
treated groups. On the other hand, 
animals administered A. laxiflora 
did not show significant reduction 
in the mean PCV on day 4 post-
infection. However, on day 7 post-
infection, animals in groups A and 
B showed a significant reduction in 
mean PCV while the mean PCV 
was significantly higher (P > 0.05) 
in group C animals when compared  
 
Figure 1: In vitro effect of different concentrations of 
methanolic extract of A. laxiflora leaf against T.  b.  brucei 
 
 
Figure 2: In vitro effect of different concentrations of 
methanolic extract of K. senegalensis leaf against T.  b. 
brucei 








Confirming the identity of any 
parasite using molecular tools in 
addition to microscopic 
observations is a basic necessity in 
any molecular biology related 
research. Plate 1 confirmed that 
the specie used in this study is T. 
b. brucei since specie specific 
primers were used for the 
amplification. The 450bp band 
size corresponds to the expected 
band size of T. b. brucei (Adams 
et al., 2006). 
The methanolic extracts of stem 
bark and leaves of K. senegalensis 
and A. laxiflora respectively have 
been shown to possess in vitro 
antitrypanosomal activity in other 
studies. Our results support those 
of Hoet et al., 2004 who showed 
that the leaf extracts of A. laxiflora 
were active in vitro against 
T.b.brucei. Whereas Henrietta et 
al., 2015, Wurochekke and Nok, 
2004; Atawodi, 2005 showed in 
vitro activity of the stem bark of 
K. senegalensis against T.b.brucei. 
In vitro, the antitrypanosomal 
activities of both extracts 
compared well with the standard 
drug suggesting they are 
efficacious in clearing parasites. 
The leaf and stem bark of A. 
laxiflora and K. senegalensis are 
used traditionally by local farmers 
in Northern Nigeria to treat 
trypanosomiasis infection. 
 
Figure 3: Prophylactic effect of different regimens of 
methanolic extract of A. laxiflora leaf (500mg/kg b.w) on 
mean parasitemia and pre-patent periods 
 
Figure 4: Prophylactic effect of different regimens of 
methanolic extract of K. senegalensis leaf (500mg/kg b.w) 
on mean parasitemia and pre-patent periods 
The results of the phytochemical analysis of 
the leaf methanol extracts of K. senegalensis 
and A. laxiflora revealed the presence of 
Saponins, Alkaloids, Flavonoid, 
Antraquinones, Resins and Tanins and 
Steriods/Terpenoids (only present in A. 
laxiflora). The antitrypanosomal and 
antimicrobial activity of some of these 
compounds, which were detected in high 
concentrations in the stem, bark methanolic 

























extracts have been previously 
demonstrated (Abbiw, 1990, 
Amvam et al., 1998, Jayanshinge et 
al., 2003 phytochemical screening 
and antibiterial activity of the bark 
extracts of A laxiflora). Nok, 2001 
and Ibrahim, 2013 attributed the 
trypanocidal activities of K. 
senegalensis to Azaanthraquinone 
and phenolics-rich fraction of the 
stem bark of the plant. 
The LD50 result showed that, the 
methanol crude extract of both A.  
laxiflora and K. Senegalensis was 
observed to have no toxicity effect 
on the experimental animals at 
concentrations of 10, 100, 1000, 
1500, 2900 and 5000mg/kg body 
weight since no mortality was 
observed at the concentration of 
5000mg/kg b.w for 24 hours. 
Therefore, it was concluded that the 
toxicity of methanolic extract of 
both A. laxiflora and K.  
senegalensis was above 5000mg/kg 
body weight, hence the choice of the 
dose concentration for the in vivo 
experiment. This result indicated 
that both plants are save to the test 
subjects since no any sign of toxicity 
or mortality was observed after 24 
hours. 
 
Figure 5: Mean Packed Cell Volume analysis of rats 
treated with 500mg/kg b.w of A. fromosia and K. 
senegalensis for the all the regimens 
Group A: To which leaf methanolic extract of A. laxiflora at 500mg/Kg/day was 
administered for one day. 
Group B: To which leaf methanolic extract of A. laxiflora at 500mg/Kg/day was 
administered for two days. 
Group C: To which leaf methanolic extract of A. laxiflora at 500mg/Kg/day was 
administered for three days. 
Group D: Infected with Trypanosoma brucei brucei but not treated. 
 Group E: Not infected and not treated. 
Group 1: To which leaf methanolic extract of K. senegalensis at 500mg/Kg/day 
was administered for one day. 
Group 2: To which leaf methanolic extract of K. senegalensis at 500mg/Kg/day 
was administered for two days. 
Group 3: To which leaf methanolic extract of K. senegalensis at 500mg/Kg/day 
was administered for three days. 
 
An interesting observation was that 
parasitemia was suppressed in the animals 
that received three doses of A. laxiflora 
extract suppressed parasitemia at an 
optimum dose of 500mg/kg body weight, 
which was clearly seen in the delayed pre-
patent period as compared to the other 
groups which received single, double or no 
treatment at all. Similarly, animals in this 
group (which received three doses of A. 
laxiflora) survived even longer than animals 
that received single, double or no treatment 
at all. This could be attributed to an 
increased concentration of active 
phytochemical components required for 
parasite clearance. On the other hand, the 
methanolic extract of K. senegalensis did 
not suppress parasitemia even after three 
administrations. However, reports have 
shown that the ethanol extract of stem bark 
of K. senegalensis posses in vivo activities 
against T. evansi (Asuzu and Chineme, 
1990; Nok et al., 1993; Ibrahim et al., 
2008). This could be attributed to the 
difference in extraction potentials in 
accordance with the polarity of the different 
organic solvents. 
Interestingly also was that animals in this 
group exhibited an increase PCV at the same 
time showing low parasitemia as seen in the 
experimental data. However, animals in the 
untreated control group exhibited severe 
anemia and concomitantly high parasitemia. 
























of the plant extract could likely be 
responsible ameliorating anemia during the 
course of the infection.  
The observed anti-trypanosomal effect of 
the extract of A. laxiflora in this study was 
accompanied by corresponding 
improvement and prevention of further drop 
in PCV suggesting that they have potentials 
to ameliorate anaemia. This could possibly 
be by reducing the proliferating parasite 
load, neutralizing the toxic metabolites 
produced by trypanosomes or scavenging 
the trypanosome associated free radicals 
(Teka et al., 2014). 
A common pathological feature observed 
during trypanosomiasis is anemia. The 
severity of anemia is often characterized by 
a drop in the PCV, which is considered as a 
pointer of the acute nature of the infection 
(D’Ieteren et al., 1998). In the Ndama breed 
of cattle, which has been known, for 
sometime to be trypanotolerant, an 
important aspect of the trypanotolerance is 
their ability to control the infection-
associated anemia. The cytokine-activated 
macrophages have been suggested to be 
responsible for the enhanced phagocytosis 
of parasites and RBCs and also inability to 
mount a vigorous compensatory 
erythropoietic response could be responsible 
for anemia during the course of the disease 
(Stijlemans et al., 2008). 
Reactive oxygen species which are 
generated by trypanosomes can also attack 
membranes of red blood cells, induce 
oxidation and eventually hemolysis. 
Therefore, phytochemicals like flavonoids 
and some other polyphenolic antioxidants 
could be used invariably to scavenge the 
trypanosome associated free radicals thus, 
ameliorating anemia induced by 
trypanosome infection (Karori et al., 2008). 
The plant extracts may strengthen the host 
defense that was already activated because 
of the presence of trypanosomes in 
circulation with established infection 
(Okeke, 2008). The mechanism by which 
these extracts exhibited their 
antitrypanosomal activity can only be 
speculated since the active ingredient(s) 
were not isolated. Several investigations 
have suggested that it is often difficult to 
speculate and elucidate the exact mode of 
action by which plant extracts exhibit their 
trypanocidal action. The most likely 
mechanisms by which plant extracts and 
phytochemicals carry out this role remains 
subject to speculations and debate in the 
scientific community (Gurib-Fakim and 
Mahomoodally, 2013). Thus, for the 
methanolic extract of A. laxiflora our study, 
the antitrypanosomal effect produced would 
most likely be ascribed to either of the 
saponins, alkaloids, flavonoids, 
antraquinones, and tannins detected in the 
extract. However, rare findings have 
suggested as to how any of these 
phytochemicals produce their 




We have established the in vitro as well as 
in vivo anti-trypanosomal effects of K. 
senegalensis and A. laxiflora in this study. 
Even though the mechanism of action has 
not been elucidated, a number of reports 
have associated anti-trypanosomal activities 
of plant extracts to some phytochemicals 
present in such plants. In vivo assay in the 
present investigation has shown that 
methanol extract of leaves of A. laxiflora 
reduced the parasite burden, am eliorated 
anaemia and extended survival of animals in 
the infected treated groups. Based on the 
data obtained, the methanol extracts of A. 
laxiflora exhibited anti-trypanosomal 
activity when compared to the methanol 
extract of stem bark of K. senegalensis 
extract. This study has therefore established 
that the leaves of A. laxiflora have anti-
trypanosomal activity could be considered a 
potential source of new drugs for the 
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